Bionano Genomics, Inc.
BNGO
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kitsā¦ read more
Healthcare
Diagnostics & Research
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.63
Price+1.24%
$0.02
1Y
Price
Market Cap
$5.483m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-64.5%
EBITDA Margin-101.8%
Net Profit Margin-51.8%
Free Cash Flow MarginRevenue
$27.426m
-10.9%
1y CAGR+1.4%
3y CAGR+14.7%
5y CAGREarnings
-$74.330m
+33.6%
1y CAGR+3.4%
3y CAGR-18.2%
5y CAGREPS
-$44.85
+49.1%
1y CAGR+33.4%
3y CAGR+6.3%
5y CAGRBook Value
$45.374m
$76.010m
Assets$30.636m
Liabilities$19.579m
DebtDebt to Assets
25.8%
-0.3x
Debt to EBITDAFree Cash Flow
-$26.064m
+62.2%
1y CAGR+36.3%
3y CAGR+8.6%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company